LangeR, VolkmerM, HeesenC, LiepertJ.Modafinil effects in multiple sclerosis patients with fatigue. J Neurol2009;256:645-50. DOI 10.1007/s00415-009-0152-7
2.
LouJS. Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment. Drugs Aging2009;26:195-208. DOI 102165/00002512-200926030-00002
3.
BlackhallL, PetroniG, ShuJ, BaumL, FaraceE.A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med2009;12:433-9. DOI 10.1089/JPM.2008.0230
4.
FavaM, ThaseME, DeBattistaC, DoghramjiK, AroraS, HughesRJ. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry2007;19:153-9. DOI 10.1080/10401230701464858
5.
RothT, WhiteD, Schmidt-NowaraW. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther2006;28:689-706. DOI 10.1016/j.clinthera.2006.05.013
6.
CzeislerCA, WalshJK, WesnesKA, AroraS, RothT.Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc2009;84:958-72. DOI 10.4065/84.11.958
7.
MendozaT, WangX, CleelandC. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer1999;85:1186-96. DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
